Blood
Heparin and low-molecular-weight heparins
Injected anticoagulants that work immediately by accelerating antithrombin; used to treat venous thromboembolism and in acute coronary syndromes.
Mécanisme d’action
- Heparin binds antithrombin, a natural inhibitor of clotting factors, and speeds its action about a thousandfold.
- Unfractionated heparin makes antithrombin inactivate both thrombin (factor IIa) and factor Xa.
- Low-molecular-weight heparins (LMWHs) are too short to bridge antithrombin and thrombin, so they act mainly on factor Xa.
- No new fibrin forms; existing clot is not dissolved, but the body’s own fibrinolysis can clear it.
Cibles moléculaires
- Antithrombin: Activator (cofactor)
- Factor Xa and thrombin: Inhibited indirectly, through antithrombin
Médicaments : Heparin and low-molecular-weight heparins
- Unfractionated heparin (Intravenous or subcutaneous; monitored with the aPTT; reversed by protamine.)
Low-molecular-weight heparins (LMWH)
- Enoxaparin (LMWH, subcutaneous; predictable effect, usually no monitoring.)
- Dalteparin (LMWH.)
Synthetic pentasaccharide (factor Xa only)
- Fondaparinux (A synthetic pentasaccharide acting only on factor Xa.)
Indications thérapeutiques
- Treatment of deep vein thrombosis and pulmonary embolism, before or alongside an oral anticoagulant
- Prevention of venous thromboembolism after surgery and in immobile patients
- Acute coronary syndromes, with antiplatelet drugs
- Anticoagulation in pregnancy, since heparins do not cross the placenta
Maladies traitées
Pharmacocinétique
- Not absorbed by mouth: given by injection.
- LMWHs are cleared by the kidney and accumulate in kidney failure.
Effets indésirables
- Bleeding
- Heparin-induced thrombocytopenia (HIT): antibodies activate platelets, causing thrombosis despite a falling platelet count
- Osteoporosis with long-term unfractionated heparin
- Hyperkalaemia, through reduced aldosterone
Contre-indications selon le terrain
- Peptic ulcer disease (Contre-indiqué): Blocking clotting stops the bleeding point sealing.
- Previous heparin-induced thrombocytopenia (Contre-indiqué): Re-exposure can trigger severe thrombosis.
- Aortic dissection (Contre-indiqué): Anticoagulation can extend bleeding within the aortic wall.
- Severe kidney impairment (LMWHs) (Avec précaution): They accumulate; unfractionated heparin is preferred.
Sujets liés
Rédigé d’après
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 21, Anticoagulants and Antiplatelet Agents, Parenteral anticoagulants
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 34, Drugs Used in Disorders of Coagulation, Heparin
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.